Louisiana Weighs Medicaid Coverage for Obesity Drugs 

Louisiana lawmakers are taking a serious look at whether Medicaid should cover more obesity treatment drugs, including well-known medications like Wegovy and Zepbound.  

For families across the state, this is the kind of proposal that gets attention fast because it touches health, cost, and access all at once. Senate Bill 433 cleared the Senate Health and Welfare Committee and is now pending Senate floor action scheduled for April 20. 

What SB433 would change 

The current version of the bill is narrower than the original proposal. As amended, it would allow Medicaid coverage for adults over 18 with a body mass index between 35 and 39 if they also have at least one related condition, including prediabetes, hypertension, or cardiovascular disease.  

The amendment also adds an important catch: the program would only move forward if lawmakers appropriate money for it. The bill’s effective date is listed as Jan. 1, 2027. 

Why supporters are pushing for it 

Backers of the bill say this is not just about weight. They argue obesity is tied to long-term medical problems that can become even more expensive if left untreated. During the committee discussion, Louisiana Health Secretary Bruce Greenstein called the medication “an absolute life changer” for some patients.  

READ MORE: Caddo Commission Proposes New Multi-Sport Complex

Supporters also argued obesity should be treated like a real medical condition, not simply a lifestyle issue. One advocate described it as a “chronic relapsing disease.” 

Why the cost question matters 

This is where the debate gets harder. Louisiana Medicaid Director Seth Gold told lawmakers annual treatment runs about $16,000 per patient, and roughly 145,000 enrollees could meet the bill’s requirements. He estimated the expansion could cost as much as $189 million in the first six months of 2027 and $296 million in the following fiscal year.  

Separately, the Legislative Fiscal Office says the bill could create an indeterminable but potentially significant increase in state and federal Medicaid spending. 

Why this matters in Louisiana 

This debate lands differently in Louisiana because the state is already dealing with high obesity rates. A March 2026 Louisiana Department of Health report says Louisiana ranked third highest in the nation for obesity in 2025.

The same report found 119,211 adult Medicaid managed care enrollees had an obesity diagnosis in 2024. That makes this more than a Capitol talking point. It is a real question about whether spending more now could help prevent bigger health problems later.